Downregulation of occludin affects the proliferation, apoptosis and metastatic properties of human lung carcinoma

Wang,Meifang; Liu,Yuquan; Qian,Xin; Wei,Na; Tang,Yijun; Yang,Jiong

doi:10.3892/or.2018.6408

Downregulation of occludin affects the proliferation, apoptosis and metastatic properties of human lung carcinoma

Authors:
- Meifang Wang
- Yuquan Liu
- Xin Qian
- Na Wei
- Yijun Tang
- Jiong Yang
View Affiliations

Affiliations: Department of Respiratory and Critical Care Medicine, Zhongnan Hospital of Wuhan University, Wuhan, Hubei 430071, P.R. China, Department of Respiratory Medicine, Taihe Hospital, Hubei University of Medicine, Shiyan, Hubei 442000, P.R. China, Department of Respiratory and Critical Care Medicine, Zhongnan Hospital of Wuhan University, Wuhan, Hubei 430071, P.R. China
Published online on: May 2, 2018 https://doi.org/10.3892/or.2018.6408
Pages: 454-462

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Lung cancer is the most frequent and deadliest cancer in the world, especially in China. However, the molecular mechanisms involved in lung cancer remain unclear. Occludin (OCLN), one of the first identified tight junction proteins, has been revealed to be a necessary integral protein for tight junction structure and function. In the present study, we investigated the role of occludin in lung tumorigenesis. We found that occludin protein expression was highly increased in human lung cancer patient samples. Western blotting results also revealed that occludin expression was different in several lung cancer cell lines, with the highest level in SPC‑A1 cells. Moreover, occludin knockdown inhibited lung cancer cell proliferation in vitro and in vivo. In addition, occludin knockdown promoted the apoptosis of lung cancer cell lines and reduced the invasion ability. Mechanistically, the activity of key growth pathway AKT/PI3K was compromised after occludin knockdown. Expression of apoptosis‑related proteins, BAX, caspase‑3, caspase‑9 and AIF, but not Bcl‑2, were upregulated after silencing of occludin. Collectively, our findings for the first time identify the role of occludin as a tumor promoter and a pro‑metastatic factor in lung cancer, demonstrating that occludin is a potential prognostic biomarker and therapeutic target in lung cancer.

View Figures

View References

1	May M: Statistics: Attacking an epidemic. Nature. 509:S50–S51. 2014. View Article : Google Scholar : PubMed/NCBI
2	Chen W, Zheng R, Baade PD, Zhang S, Zeng H, Bray F, Jemal A, Yu XQ and He J: Cancer statistics in China, 2015. CA Cancer J Clin. 66:115–132. 2016. View Article : Google Scholar : PubMed/NCBI
3	Fidler IJ: The pathogenesis of cancer metastasis: The ‘seed and soil’ hypothesis revisited. Nat Rev Cancer. 3:453–458. 2003. View Article : Google Scholar : PubMed/NCBI
4	Sone S and Yano S: Molecular pathogenesis and its therapeutic modalities of lung cancer metastasis to bone. Cancer Metastasis Rev. 26:685–689. 2007. View Article : Google Scholar : PubMed/NCBI
5	Hanahan D and Weinberg RA: Hallmarks of cancer: The next generation. Cell. 144:646–674. 2011. View Article : Google Scholar : PubMed/NCBI
6	Tobioka H, Sawada N, Zhong Y and Mori M: Enhanced paracellular barrier function of rat mesothelial cells partially protects against cancer cell penetration. Br J Cancer. 74:439–445. 1996. View Article : Google Scholar : PubMed/NCBI
7	Haynes MD, Martin TA, Jenkins SA, Kynaston HG, Matthews PN and Jiang WG: Tight junctions and bladder cancer (Review). Int J Mol Med. 16:3–9. 2005.PubMed/NCBI
8	Furuse M, Hirase T, Itoh M, Nagafuchi A, Yonemura S and Tsukita S and Tsukita S: Occludin: A novel integral membrane protein localizing at tight junctions. J Cell Biol. 123:1777–1788. 1993. View Article : Google Scholar : PubMed/NCBI
9	Jiang WG, Bryce RP, Horrobin DF and Mansel RE: Regulation of tight junction permeability and occludin expression by polyunsaturated fatty acids. Biochem Biophys Res Commun. 244:414–420. 1998. View Article : Google Scholar : PubMed/NCBI
10	Tsukita S, Furuse M and Itoh M: Multifunctional strands in tight junctions. Nat Rev Mol Cell Biol. 2:285–293. 2001. View Article : Google Scholar : PubMed/NCBI
11	Wittchen ES, Haskins J and Stevenson BR: Protein interactions at the tight junction. Actin has multiple binding partners, and ZO-1 forms independent complexes with ZO-2 and ZO-3. J Biol Chem. 274:35179–35185. 1999. View Article : Google Scholar : PubMed/NCBI
12	Aijaz S, Balda MS and Matter K: Tight junctions: Molecular architecture and function. Int Rev Cytol. 248:261–298. 2006. View Article : Google Scholar : PubMed/NCBI
13	Murata M, Kojima T, Yamamoto T, Go M, Takano K, Osanai M, Chiba H and Sawada N: Down-regulation of survival signaling through MAPK and Akt in occludin-deficient mouse hepatocytes in vitro. Exp Cell Res. 310:140–151. 2005. View Article : Google Scholar : PubMed/NCBI
14	Michl P, Barth C, Buchholz M, Lerch MM, Rolke M, Holzmann KH, Menke A, Fensterer H, Giehl K, Löhr M, et al: Claudin-4 expression decreases invasiveness and metastatic potential of pancreatic cancer. Cancer Res. 63:6265–6271. 2003.PubMed/NCBI
15	Wang Z, Mandell KJ, Parkos CA, Mrsny RJ and Nusrat A: The second loop of occludin is required for suppression of Raf1-induced tumor growth. Oncogene. 24:4412–4420. 2005. View Article : Google Scholar : PubMed/NCBI
16	Hoevel T, Macek R, Swisshelm K and Kubbies M: Reexpression of the TJ protein CLDN1 induces apoptosis in breast tumor spheroids. Int J Cancer. 108:374–383. 2004. View Article : Google Scholar : PubMed/NCBI
17	Li ZM, Tian T, Lv F, Chang Y, Wang X, Zhang L, Li X, Li L, Ma W, Wu J and Zhang M: Six1 promotes proliferation of pancreatic cancer cells via upregulation of cyclin D1 expression. PLoS One n. 8:e592032013. View Article : Google Scholar
18	Schneeberger EE and Lynch RD: Structure, function, and regulation of cellular tight junctions. Am J Physiol. 262:L647–L661. 1992.PubMed/NCBI
19	Gumbiner BM: Breaking through the tight junction barrier. J Cell Biol. 123:1631–1633. 1993. View Article : Google Scholar : PubMed/NCBI
20	Burgering BM and Coffer PJ: Protein kinase B (c-Akt) in phosphatidylinositol-3-OH kinase signal transduction. Nature. 376:599–602. 1995. View Article : Google Scholar : PubMed/NCBI
21	Franke TF, Yang SI, Chan TO, Datta K, Kazlauskas A, Morrison DK, Kaplan DR and Tsichlis PN: The protein kinase encoded by the Akt proto-oncogene is a target of the PDGF-activated phosphatidylinositol 3-kinase. Cell. 81:727–736. 1995. View Article : Google Scholar : PubMed/NCBI
22	Fisher DE: Apoptosis in cancer therapy: Crossing the threshold. Cell. 78:539–542. 1994. View Article : Google Scholar : PubMed/NCBI
23	Evan GI and Vousden KH: Proliferation, cell cycle and apoptosis in cancer. Nature. 411:342–348. 2001. View Article : Google Scholar : PubMed/NCBI
24	Gozani O, Boyce M, Yoo L, Karuman P and Yuan J: Life and death in paradise. Nat Cell Biol. 4:E159–E162. 2002. View Article : Google Scholar : PubMed/NCBI
25	Gu JM, Lim SO, Park YM and Jung G: A novel splice variant of occludin deleted in exon 9 and its role in cell apoptosis and invasion. FEBS J. 275:3145–3156. 2008. View Article : Google Scholar : PubMed/NCBI
26	Beeman NE, Baumgartner HK, Webb PG, Schaack JB and Neville MC: Disruption of occludin function in polarized epithelial cells activates the extrinsic pathway of apoptosis leading to cell extrusion without loss of transepithelial resistance. BMC Cell Biol. 10:852009. View Article : Google Scholar : PubMed/NCBI
27	Wang X: The expanding role of mitochondria in apoptosis. Genes Dev. 15:2922–2933. 2001.PubMed/NCBI
28	Osanai M, Murata M, Nishikiori N, Chiba H, Kojima T and Sawada N: Epigenetic silencing of occludin promotes tumorigenic and metastatic properties of cancer cells via modulations of unique sets of apoptosis-associated genes. Cancer Res. 66:9125–9133. 2006. View Article : Google Scholar : PubMed/NCBI
29	Bogenrieder T and Herlyn M: Axis of evil: Molecular mechanisms of cancer metastasis. Oncogene. 22:6524–6536. 2003. View Article : Google Scholar : PubMed/NCBI